Washington state companies raised $450.1 million in the second quarter, led by a $195M round to Adaptive Biotechnologies.
Seattle startups are in no hurry to go public. That’s become increasingly the trend as venture capital keeps flowing to the region’s companies, enabling them to stay private for longer periods of time.
The money continued to flow in the first half of this year, with Washington companies raising $1.1 billion in venture-capital funding during that period, according to the quarterly Dow Jones VentureSource report being released Thursday.
The second-quarter results show Washington state startups raised $444.5 million, a 6 percent increase from the second quarter of 2014.
And though that represented a decline from first-quarter investments, there were more deals in the second quarter, 34 compared with 30 in the first.
Most Read Stories
- Huskies get commitment from Coeur d'Alene 4-star QB Colson Yankoff
- Aerospace firm Electroimpact agrees to pay $485K after AG finds ‘shocking’ discrimination against Muslims
- $225 million more needed to build light rail across I-90 bridge
- Poutine is the new nachos: where to find the best versions in the Seattle area
- 'I'm amazed tourists ever come back': Your comments on Seattle's poor tourism survey
“This is the strongest start we’ve had to a year in the last five-plus years,” said Greg Beams, a partner at Ernst & Young in Seattle.
In the past 12 months, companies raised more than $2.1 billion, a record as far as Beams knows. That proves the continued strong funding in the region is a trend, not just a “flash in the pan,” he said.
That kind of growth in financing is helping tech companies stay private longer than they used to. Companies are now an average of 11 years old when they make an initial public offering, up from an average of 5 years old in 2000, according to The Wall Street Journal.
In Washington state, late-stage companies are raising larger and larger rounds. Bellevue’s K2, a business-software company, raised $153 million in April. Adaptive Biotechnologies, which examines the genetic makeup of the immune system to help fight cancer, raked in $195 million in May. And Chef, a Seattle software company that helps businesses manage their technology infrastructure, brought in $32 million in a round that is still ongoing.
Those companies have amassed massive amounts of total funding — in Adaptive’s case that number is nearly $400 million — and show no imminent desire to go the IPO route.
Data from Dow Jones Venture Source show that companies now have a median valuation prior to recent financing of $65 million, up from $18.8 million three years ago. The largest deals nationally in the second quarter were nearly all late-stage financing rounds, including a $278.1 million round from DocuSign, which was founded in Seattle and is now based in San Francisco.
Nationally, businesses took in $19.19 billion in venture capital during the second quarter, a 24 percent increase from the same period in 2014. The number of deals was slightly lower than in the second quarter of 2014.
“What’s happening in Seattle, even though it’s a fairly small ecosystem, mirrors what we’re seeing on a national level,” said Adley Bowden, senior director of research and analysis at Seattle investment research company PitchBook Data. “There are late-stage companies raising significant amounts of money and a healthy number of smaller angel deals.”
Adaptive’s $195 million was the largest deal in the second quarter, according to Dow Jones VentureSource. Arivale, a Seattle health-care services company, was next at $36 million, followed by digital advertising services company iSpot.tv’s $21.9 million. A later-stage round for Carena, another health-care company, followed with $13.3 million.
Beams compares the large, late-stage funding rounds to an almost “private IPO.” With access to private capital, companies can keep running without jumping through the hurdles of going public or the headaches of managing thousands of shareholders.
Staying private means thinking about the long-term, founders of Seattle-area startups say, rather than trying to impress investors quarter by quarter. The overall thought seems to be: Why deal with the regulatory and financial pains of going public when large funds can be raised in the private market?
“Quite frankly, we wouldn’t go public now or in the next year,” said Peter Godman, CEO of Seattle data-storage company Qumulo, which raised a $40 million round in March, bringing total funding to nearly $67 million. “We’re in a situation where we’re fortunate enough to raise a lot of money to build our business.”
Some companies are taking advantage of investors’ recent giving moods and stockpiling cash for the future.
“In our case, this is more about future plans than current needs,” Chef CEO Barry Crist said. “We’re building a company of very lasting value.”
Most of these companies do plan to go public eventually, but they aren’t in a hurry to rush into the world of quarterly reports and watchful shareholders.
In Washington, three of the four largest deals from this quarter went to companies in the health or biotech fields, which are industries where IPO activity has continued to stay active.
“We are seeing dollars continue to follow into that industry, which is consistent in terms of where we are seeing IPOs,” Beams said.